Interacting with γSecretase for Treating Alzheimer's Disease: From Inhibition to Modulation

By  

Current Medicinal Chemistry, Vol. 18, Iss. 35, 2011-12 ,pp. : 5430-5447

Bentham Science Publishers

Access to resources Recommend Favorite

Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012

By Pettersson Martin   Stepan Antonia F   Kauffman Gregory W   Johnson Douglas S  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1349-1366

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of γ-Secretase as a Therapeutic Intervention for Alzheimer's Disease: Prospects, Limitations and Strategies

By Evin Geneviève   Marijke Fleur Sernee   Masters Colin L.  

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 351-372

Adis International

Access to resources Recommend Favorite

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

By D'Onofrio Grazia   Panza Francesco   Frisardi Vincenza   Solfrizzi Vincenzo   Imbimbo Bruno P   Paroni Giulia   Cascavilla Leandro   Seripa Davide   Pilotto Alberto  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 19-37

Informa Healthcare

Access to resources Recommend Favorite

&ggr;-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1555-1570

Bentham Science Publishers

Access to resources Recommend Favorite